231 related articles for article (PubMed ID: 31093305)
1. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y
Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305
[TBL] [Abstract][Full Text] [Related]
2. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C
Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240
[TBL] [Abstract][Full Text] [Related]
3. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
4. KIF5A Promotes Bladder Cancer Proliferation
Tian DW; Wu ZL; Jiang LM; Gao J; Wu CL; Hu HL
Dis Markers; 2019; 2019():4824902. PubMed ID: 31354888
[TBL] [Abstract][Full Text] [Related]
5. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X
Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408
[TBL] [Abstract][Full Text] [Related]
6. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
Zhou Q; Yu J; Zheng Q; Wu T; Ji Z; Zhuo Y
FEBS Open Bio; 2021 May; 11(5):1487-1496. PubMed ID: 31774623
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
[TBL] [Abstract][Full Text] [Related]
8. Role of a Kinesin Motor in Cancer Cell Mechanics.
Mandal K; Pogoda K; Nandi S; Mathieu S; Kasri A; Klein E; Radvanyi F; Goud B; Janmey PA; Manneville JB
Nano Lett; 2019 Nov; 19(11):7691-7702. PubMed ID: 31565944
[TBL] [Abstract][Full Text] [Related]
9. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.
Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T
Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
11. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC.
Wu C; Qi X; Qiu Z; Deng G; Zhong L
Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228
[TBL] [Abstract][Full Text] [Related]
12. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
[TBL] [Abstract][Full Text] [Related]
13. High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma.
Liu B; Su J; Fan B; Ni X; Jin T
Medicine (Baltimore); 2023 Jan; 102(2):e32667. PubMed ID: 36637953
[TBL] [Abstract][Full Text] [Related]
14. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
15. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
17. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
18. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.
Zhang XG; Zhang T; Li CY; Zhang MH; Chen FM
Cancer Med; 2018 Aug; 7(8):3763-3772. PubMed ID: 30022623
[TBL] [Abstract][Full Text] [Related]
19. C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients.
Zhu X; Tong H; Gao S; Yin H; Zhu G; Li X; He W; Gou X
Biomed Res Int; 2020; 2020():7139721. PubMed ID: 33123583
[TBL] [Abstract][Full Text] [Related]
20. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
